Companies Dominating the Cancer Services Landscape
- Siemens Healthcare GmbH
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Fonar Corporation
- Koninklijke Philips N.V.
- Shimadzu Corporation
- Abbott Laboratories
- Samsung Medison Co., Ltd.
- Eli Lilly and Company
- Hologic, Inc.
- Novartis International AG
- GE Group
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Cancer Services Market size is poised to grow at over 20.4% CAGR during the forecast period i.e., between 2025-2037.
Increasing cases of cancer, a rising geriatric population, and growing consumption of alcohol, cigarettes, and tobacco will boost the market growth.
North America industry is poised to account for largest revenue share by 2037, impelled by higher prevalence of cancer, developing technologies for the treatment and prevention of cancer, and growing healthcare expenditure.
The major players in the market are Siemens Healthcare GmbH, Fonar Corporation, Koninklijke Philips N.V., Shimadzu Corporation, Abbott Laboratories, Samsung Medison Co., Ltd., Eli Lilly and Company, Hologic, Inc., Novartis International AG, and GE Group.
